Advisory Committee for Pharmaceutical Science and Clinical Pharmacology

Advisory Committee for Pharmaceutical Science and Clinical Pharmacology [Committee Meeting August 9, 2012 8:00 a.m. to 5:00 p.m. (Day 2 of 2) Agenda: During the morning session, the committee will discuss FDA''s draft guidance on tablet scoring. This topic will include an overview of FDA''s proposed plan to move forward and the United States Pharmacopoeia’s (USP) perspective on the topic. During the afternoon session, the committee will discuss: (1) the Center for Drug Evaluation and Research (CDER) Nanotechnology Risk Management Working Group activities; (2) nanotechnology-related research conducted and published by CDER, to include examples related to sunscreens; and (3) the overview and preliminary analysis of nanotechnology-related information collected from drug application submissions.